Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTurkiye Gdr Rgs Regulatory News (TIBD)

Share Price Information for Turkiye Gdr Rgs (TIBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.38
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 3.38
High: 0.00
Low: 0.00
Prev. Close: 3.38
TIBD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

The Sale of Participations

22 Aug 2008 10:08

RNS Number : 8795B
Turkiye Is Bankasi
22 August 2008
 



21.08.2008 The Sale of Turk Pirelli Lastikleri A.S. and Celikord A.S. 

Related to our letter dated 17.07.2008 nr.CY-779 

As per the resolution of the Board of Directors dated 21.08.2008, the sale of 

Isbank's 25.75 % share in Turk Pirelli Lastikleri A.S. with a nominal value of TRY 36,055,801.01 for an amount of TRY 46,500,000 in cash and, 

Isbank's 48% share in Celikord A.S. with a nominal value of TRY 13,920,000.00 for an amount of TRY 28,500,000 in cash 

to Pirelli Tyre Holland N.V., which is one of the major and current shareholders in Pirelli Group, has been ratified. The Head Office has been authorized to sign the sales agreement and related documents, and execute the transactions for the sale of Isbank's abovementioned shares. 

The sales agreement was signed on 21.08.2008 and a total amount of TRY 75,000,000 has been collected as the sales value in exchange for the receipts delivered to the buyer. 

The valuation of an expert consultancy firm in 2007 and bargaining in the light of financial statements determined the share price. 

After the finalization of the sale, Isbank will have no direct share in Turk Pirelli Lastikleri A.S. and Celikord A.S. 

TRY 6,893,363.63 of profit from the sale of Turk Pirelli Lastikleri A.S. and TRY 5,515,374.34 of profit from the sale Celikord A.S. are realized from sale of shares, according to their  net balance sheet values. There has not been any decision taken by the Board of Directors related to the use of the total sales profit of TRY 12,408,757.97.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIIFIATRIFFIT
Date   Source Headline
2nd Apr 20247:00 amRNSResolutions Made at the Annual General Meeting
18th Mar 20249:07 amRNSCredit Rating
14th Feb 20247:00 amRNS2023 Year-End Financial Statements
18th Jan 20248:30 amRNSCredit Rating
6th Nov 20236:03 pmRNS2023 Third Quarter Financial Statements
25th Sep 202310:15 amRNSCredit Rating
29th Aug 20237:00 amRNSNotification Regarding Demerger
8th Aug 20237:00 amRNS2023 First Half Financial Statements
10th May 20237:00 amRNS2023 First Quarter Financial Statements
27th Feb 20239:48 amRNSCredit Rating
8th Feb 20237:00 amRNS2022 Year-End Consolidated Financial Statements
7th Feb 20237:00 amRNS2022 Year-End Bank-Only Financial Statements
7th Feb 20237:00 amRNSForward Looking Evaluations
15th Nov 20224:05 pmRNS2022 Q3 Consolidated Financial Statements
8th Nov 20227:00 amRNS2022 Third Quarter Bank-Only Financial Statements
2nd Sep 20224:10 pmRNSElection of Home Member State
17th Aug 202212:19 pmRNSCredit Rating
9th Aug 20227:00 amRNS2022 First Half Financial Statements
27th Jul 202212:54 pmRNSCredit Rating
24th May 20223:44 pmRNSTermination of the Credit Rating Service from S&P
10th May 20227:00 amRNS2022 First Quarter Financial Statements
28th Apr 20225:31 pmRNS2021 YE IFRS Consolidated Financial Statements
1st Apr 20224:20 pmRNSCredit Rating
1st Mar 20221:03 pmRNSCredit Rating
17th Feb 20222:52 pmRNSCredit Rating
9th Feb 20227:00 amRNSForward Looking Evaluations
16th Dec 20211:57 pmRNSCredit Rating
13th Dec 20211:51 pmRNSCredit Rating
5th Nov 20216:27 pmRNS2021 Third Quarter Financial Statements
22nd Oct 20214:08 pmRNS2021 H1 IFRS Consolidated Financial Statements
11th Aug 20217:00 amRNS2021 First Half Financial Statements
7th May 20216:17 pmRNS2021 First Quarter Financial Statements
30th Apr 20215:20 pmRNS2020 YE IFRS Based Consolidated Financials
26th Feb 20215:20 pmRNSCredit Rating
17th Feb 20213:18 pmRNSCredit Rating
8th Feb 20214:55 pmRNS2020 Year-End Financial Statements
8th Jan 20212:42 pmRNSForward Looking Evaluations
6th Jan 20212:28 pmRNSMaterial Event Disclosure
11th Dec 20202:12 pmRNSMoody's Rating Action
6th Nov 20205:50 pmRNS2020 Third Quarter Financial Statements
30th Oct 20204:25 pmRNS2020-H1 IFRS Based Consolidated Financials
17th Sep 20201:34 pmRNSCredit Rating
7th Aug 20205:48 pmRNS2020 First Half Financial Statements
11th May 20207:00 amRNS2020 First Quarter Financial Statements
1st May 20207:00 amRNS2019 YE IFRS Based Consolidated Financials
7th Feb 20205:50 pmRNS2019 Year-End Financial Statements
8th Jan 20203:10 pmRNSForward Looking Evaluations
6th Nov 20196:11 pmRNSIsbank 3rd Quarter Financial Results
27th Sep 20192:43 pmRNSElection of Home Member State
8th Aug 20195:52 pmRNS2019 First Half Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.